Avg closing price
Price range

8 Cathie Wood 10x Genomics- Class A Trades

Cathie Wood's position in 10x Genomics- Class A is currently worth $168 Million. That's 1.01% of their equity portfolio (27th largest holding). The investor owns 3.86% of the outstanding 10x Genomics- Class A stock. The first 10x Genomics- Class A trade was made in Q2 2020. Since then Cathie Wood bought shares four more times and sold shares on three occasions. The investor's estimated purchase price is $522 Million, resulting in a loss of 68%.

Avg closing price
Price range
Increased shares by 27.5% (+730 Thousand shares) Q1 2022
Avg closing price $87.48
Price range $55.70 - $145.79
Sold 14.2% shares (-441 Thousand shares) Q4 2021
Avg closing price $153.17
Price range $135.05 - $182.59
Sold 27.9% shares (-1.2 Million shares) Q3 2021
Avg closing price $171.69
Price range $145.58 - $192.14
Increased shares by 22.7% (+796 Thousand shares) Q2 2021
Avg closing price $180.98
Price range $134.22 - $202.37
Increased shares by 556.8% (+2.97 Million shares) Q1 2021
Avg closing price $172.69
Price range $140.25 - $196.86
Increased shares by 130.9% (+302 Thousand shares) Q4 2020
Avg closing price $145.11
Price range $126.47 - $163.70
Sold 31.3% shares (-105 Thousand shares) Q3 2020
Avg closing price $104.97
Price range $87.44 - $125.00
New holding (+337 Thousand shares) Q2 2020
Avg closing price $77.89
Price range $58.39 - $89.31

News about 10x Genomics Inc - Class A and Cathie Wood

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!